Navigation Links
PRC Government Grants High-Tech Status to AOBO Subsidiaries
Date:1/13/2009

t the subsidiary level. By having this recognition from the government, we are laying the groundwork for our future growth with eligibility for government funding and grant incentives. We are truly proud that AOBO achieved this esteemed status, especially given that very few companies have successfully achieved this status."

High-tech status is awarded by the PRC to recognize companies that consistently invest in new product development, and have substantial revenues generated by their own proprietary patented or innovative products. In this way, the Chinese government encourages domestic and foreign investment in advanced technologies, and has created a series of preferential tax policies to stimulate and promote the production of high-tech products, the provision of high-tech related services and technology transfers into and within China. The Ministry of Science and Technology of China, the Ministry of Finance and the State Administration of Taxation jointly promulgated the Measures For the Recognition and Administration of New and High-Tech Enterprises, which clearly specifies the requirements for the recognition and administration of new and high-tech enterprises.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China.

Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The economic, competitive, governmental, technological and other factors identified in the Company's filings with the Securities and Exchange Commiss
'/>"/>

SOURCE American Oriental Bioengineering, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Maureen Mo Zilly Joins the Varian Medical Systems Government Affairs Team as Director, Federal Affairs
2. Atlantica Bioenergy Task Force hosts industry and government leaders
3. SenesTech, Inc. Commences Product Registration Process With Australian Government
4. San Diego universities, government and industry rally around local Clean-Tech cluster
5. Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics
6. Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices
7. Enigma Diagnostics Announces an Award of GBP 1.8 Million From UK Government
8. Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers
9. Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene
10. CBO: Biogenerics Would Save Federal Government $6.6 Billion Over Ten Years
11. BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, Chromium - Global Market Trends ,...--Global-Market-Trends.html ,, Worldwide deman...s steel, while growth in aerospace and industrial ...f chromium metal. Environmental constraints and ra...
(Date:12/1/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, Emerging Clinical Trial Locations - Ea...lthcare and regulatory environment ,, http://...ial-Locations---Eastern-Europe-Market-dynamics-and...t.html ,, Over the last decade pharmaceutical ...
(Date:12/1/2009)...ec. 1 To address the emergence of ...potential, a group of individuals and companies an...ustry Association (SynBIA) in Cambridge, Massachus...provide a forum for individuals and commercial int...portunities and its challenges, and advocate for i...
(Date:12/1/2009)...ewswire-Asia/ -- Shanghai ChemPartner, as the,flag...sed Contract Research,Organization (CRO), today an...logy Fast 50 China, ranking 3rd on the list of the... award is a testament to ChemPartner,s outstanding..., The results of the 2009 Deloitte Technology...
Breaking Biology Technology:Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3
...nnounced Tuesday its release of GroupWise Migrator... that automates the migration of server and deskto.... , ,Earlier versions of GroupWise Migrator for E...ress books, frequent contacts and personal distrib...rsion adds the ability to migrate large GroupWise ...
...oped by a research group headed by Nimmi Ramanujam... the University of Wisconsin-Madison, will be a "t...the chance for an accurate clinical diagnosis of b...trasound - two-dimensional pictures - to guide the... ensure that they are doing the biopsy at the righ...
...ilding better advertising campaigns may be to buil...dy from the University of Wisconsin-Oshkosh, consu...t the information they get from traditional advert...o online to learn more are likely to perform bette...estination. , ,Integrating ads with a web site can...
Other Biology Technology:Wingra Technologies releases new e-mail-message migration software 2Technology could enhance accuracy of breast biopsy 2To boost advertising results, consider improving your web site 2
(Date:11/30/2009)...e state of Antarctica,s climate and its relationsh...week (Tuesday 1 December) by the Scientific Commit...tarctic Climate Change and the Environment presen...ntifies areas for future scientific research, and ...have about Antarctic melting, sea-level rise and b...
(Date:11/30/2009)... team overcame a major hurdle plaguing the develop...d to more efficient catalysts used to produce hydr...chers reported Nov. 29 in Nature Materials the f...n metallic nanoparticles, the vaunted next-generat...me heat. , Gtz Veser, an associate professor and...
(Date:11/30/2009)...imental Biology are pleased to announce that Dr X...Scientifique (CNRS) in the Universit de Nice-Sophi...standing Paper Prize. ,The prize is awarded in rec...nded to encourage young scientists, says Hans Hop...we truly appreciate when authors submit their very...
Breaking Biology News(10 mins):First comprehensive review of the state of Antarctica's climate 2First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Immucor to Announce Fiscal First Quarter Financial Results on Thursday October 1 2009 57569 1Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 1Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 2Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 3Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 4Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 5Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 6Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 7Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 1Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 3Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 4Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 5Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 6Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 7
...earch into a new treatment for nerve damage caused...betic patients, say experts. , The treatment migh...d feet if early effects on nerve protection and re...in diabetes is the major cause of non-traumatic lo..., Scientists at The University of Manchester, work...
... did University of Alberta researchers discover th...? A little birdie told them. , In studying the sp...niversity of Alberta researchers were surprised to...hat showed how animals navigate. This study is the...only animals that had been raised in human-made en...
...pared with a long-used linear model, a correlation...o map complex gene interactions and pinpoint genes...ccording to new Brown University research. , The ...sing new tool for tracing human gene connections, ...cer and other diseases. Results appeared this week...
Other Biology News:Diabetic nerve therapy shows 'striking' results 2Chickadees can help humans get their bearings 2Researchers develop promising new gene network analysis method 2
Goat Anti-Human Nebraska Calf Diarrhea Virus Polyclonal Antibody, FITC Conjugated from Abcam
Rat Anti-Mouse CD205 (DEC-205) Monoclonal Antibody, Unconjugated, Clone NLDC-145 from Cell Sciences
Mouse Anti-Human Clusterin alpha chain Monoclonal Antibody, Unconjugated, Clone 41D from Upstate
Proteinase K from EPICENTRE Biotechnologies
Biology Products: